MASLD and MetALD had a higher risk of CVD compared to no SLD with an increasing trend, suggesting that cardiometabolic risk factors and alcohol consumption may additively contribute to CVD risk enabling more granular risk stratification.
← all excerpts
Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study.
1
—
—